Skip to main content
. 2023 Jul 3;6(7):943–969. doi: 10.1021/acsptsci.3c00047

Figure 13.

Figure 13

Analysis of proliferative diseases claimed by patents related to mRNA therapeutics and vaccines: red, more than 100 patents; orange, 50–100 patents; blue, less than 50 patents.